Related Experiment Video

Updated: May 18, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Divergent antiviral effects of bioflavonoids on the hepatitis C virus life cycle

Ronik Khachatoorian1, Vaithilingaraja Arumugaswami, Santanu Raychaudhuri

  • 1Molecular Biology Interdepartmental Ph.D. Program, Molecular Biology Institute, David Geffen School of Medicine at University of California, Los Angeles, California, CA, United States. RnKhch@ucla.edu

Virology
|September 15, 2012
PubMed

Insights

Quercetin, catechin, and naringenin show antiviral effects against hepatitis C virus (HCV) without toxicity. These bioflavonoids target different viral mechanisms, suggesting combination therapy could be effective for HCV treatment.

Area of Science:

  • Virology
  • Pharmacology
  • Biochemistry

Background:

  • Hepatitis C virus (HCV) proliferation is a significant global health concern.
  • Quercetin, a bioflavonoid, previously showed potential in inhibiting HCV by targeting viral translation.
  • Understanding the mechanisms of action for various bioflavonoids is crucial for developing novel antiviral strategies.

Purpose of the Study:

  • To investigate the antiviral mechanisms of quercetin and six other bioflavonoids against HCV.
  • To compare the efficacy and specific targets of these compounds in inhibiting viral replication.
  • To explore the potential for synergistic effects when combining different bioflavonoids.

Main Methods:

  • Antiviral activity assays were performed on HCV-infected cells.
  • Cytotoxicity was assessed to determine safety profiles.
  • Internal ribosomal entry site (IRES)-mediated translation assays were used to evaluate effects on viral genome translation.
  • Infectious virion secretion and assembly were measured.
  • Heat shock protein 70 (HSP70) induction was analyzed.

Main Results:

  • Catechin, naringenin, and quercetin exhibited significant antiviral activity against HCV without cytotoxicity.
  • Quercetin strongly inhibited viral translation and NS5A-augmented IRES-mediated translation.
  • Catechin and naringenin showed moderate inhibition of viral translation and IRES activity, but stronger inhibition of virion assembly compared to quercetin.
  • Differential inhibition of HSP70 induction was observed among the tested bioflavonoids.

Conclusions:

  • The antiviral effects of quercetin, catechin, and naringenin against HCV are mediated through distinct molecular mechanisms.
  • Quercetin primarily targets viral translation, while catechin and naringenin impact virion assembly and show milder effects on translation.
  • The diverse mechanisms suggest that combining these bioflavonoids could offer synergistic antiviral activity against HCV.

More Related Videos

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus06:28

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus

Published on: October 1, 2015

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...